Fig. 3
From: Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression
USP7 enhances the metastasis of ERPBC cells. (A) Migration of MCF7 (upper) and T47D (lower) cells with silencing assessed via an in vitro migration assay. (B) Quantitative analysis of migration of MCF7- (left) and T47D- (right) USP7-silenced cells. (C) Invasiveness of MCF7 (upper) and T47D (lower) cells with silencing assessed via an in vitro invasion assay. (D) Quantitative analysis of MCF7- (left) and T47D- (right) USP7-silenced cell invasiveness